FXYD5 and ovarian cancer: Evaluation of Gα13-specific signalingpathways in SKOV3 or HeyA8 ovarian cancer cell lines indicate that Ric-8Apotentiates Gα13-mediated activation of RhoA, Cdc42, and thedownstream p38MAPK.